Literature DB >> 10081507

Penicillin-binding protein-mediated resistance in pneumococci and staphylococci.

H F Chambers1.   

Abstract

Target alteration underlies resistance to beta-lactam antibiotics in both Staphylococcus species and Streptococcus pneumoniae. The penicillin-binding protein (PBP) targets in penicillin-resistant strains of S. pneumoniae are modified, low-binding-affinity versions of the native PBPs. Multiple PBP targets may be modified by transformation and homologous recombination with DNA from PBP genes of viridans streptococci. The level of resistance is determined by how many and to what extent targets are modified. In contrast, methicillin resistance in staphylococci is due to expression of PBP 2a, a novel, low-affinity PBP for which there is no homologue in methicillin-susceptible strains. PBP 2a is encoded by mecA, a highly conserved gene most likely acquired by a rare transposition from Staphylococcus sciuri or a closely related ancestor. Expression of resistance can be highly variable, but this seems not to be determined by PBP modifications. Several non-PBP factors are required for high-level resistance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10081507     DOI: 10.1086/513854

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus.

Authors:  W H Zhao; Z Q Hu; S Okubo; Y Hara; T Shimamura
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Evolution and virulence of serogroup 6 pneumococci on a global scale.

Authors:  D Ashley Robinson; David E Briles; Marilyn J Crain; Susan K Hollingshead
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

3.  Genomic analyses of DNA transformation and penicillin resistance in Streptococcus pneumoniae clinical isolates.

Authors:  Fereshteh Fani; Philippe Leprohon; George G Zhanel; Michel G Bergeron; Marc Ouellette
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

4.  Identification of Salmonella enterica serovar Pullorum antigenic determinants expressed in vivo.

Authors:  Qiuchun Li; Yachen Hu; Jing Chen; Zhicheng Liu; Jun Han; Lin Sun; Xinan Jiao
Journal:  Infect Immun       Date:  2013-06-17       Impact factor: 3.441

5.  Direct quantitation of the numbers of individual penicillin-binding proteins per cell in Staphylococcus aureus.

Authors:  Michael J Pucci; Thomas J Dougherty
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

6.  Excretion of beta-lactam antibiotics in sweat--a neglected mechanism for development of antibiotic resistance?

Authors:  N Hoiby; C Pers; H K Johansen; H Hansen
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 7.  What we may expect from novel antibacterial agents in the pipeline with respect to resistance and pharmacodynamic principles.

Authors:  Karen Bush; Malcolm G P Page
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-02-04       Impact factor: 2.745

8.  Structure-based optimization of a non-beta-lactam lead results in inhibitors that do not up-regulate beta-lactamase expression in cell culture.

Authors:  Donatella Tondi; Federica Morandi; Richard Bonnet; M Paola Costi; Brian K Shoichet
Journal:  J Am Chem Soc       Date:  2005-04-06       Impact factor: 15.419

Review 9.  Stress Physiology of Lactic Acid Bacteria.

Authors:  Konstantinos Papadimitriou; Ángel Alegría; Peter A Bron; Maria de Angelis; Marco Gobbetti; Michiel Kleerebezem; José A Lemos; Daniel M Linares; Paul Ross; Catherine Stanton; Francesca Turroni; Douwe van Sinderen; Pekka Varmanen; Marco Ventura; Manuel Zúñiga; Effie Tsakalidou; Jan Kok
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

10.  Reactions of peptidoglycan-mimetic beta-lactams with penicillin-binding proteins in vivo and in membranes.

Authors:  Ish Kumar; Helen R Josephine; R F Pratt
Journal:  ACS Chem Biol       Date:  2007-09-21       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.